Clinical Professor, Medicine and Surgery, UCLA School of Medicine Medical Director, Dumont-UCLA Liver Transplant Program
Gastroenterology
Dr. Francisco A. Durazo, MD
|
|
Give Review
Dr. Francisco A. Durazo practices Gastroenterology. He has 1 awards "Super Doctor". Francisco A. Durazo is a published doctor and has 57 publications published. The lastest was: 'Effect of single and repeated doses of metoclopramide on the mechanisms of gastroesophageal reflux.' He is registered with Medicare and accepts Medicare payments.
Publications
- Sofosbuvir and simeprevir is effective for recurrent Hepatitis C in liver transplant recipients.
- Boceprevir in liver transplant recipients.
- Liver Transplantation in Highest Acuity Recipients: Identifying Factors to Avoid Futility.
- Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
- Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
- A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
- Hepatotoxicity due to hydroxycut: a case series.
- Endoscopic treatment of postorthotopic liver transplantation anastomotic Biliary strictures with maximal stent therapy (with video).
- A comparison of Hepatitis B viral markers of patients in different clinical stages of chronic infection.
- Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive Cirrhosis.
- Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic Biliary strictures.
- Fulminant liver failure due to usnic acid for weight loss.
- Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results.
- Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis.
- Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model.
- MELD score predicts 1-year patient survival post-orthotopic liver transplantation.
- Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic Cirrhosis: a decision analytic model.
- Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.
- Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent Hepatitis C.
- Conversion from intravenous to intramuscular Hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prop...
- Donor and recipient outcomes in right lobe adult living donor liver transplantation.
- A model to predict the development of mental status changes of unclear cause after liver transplantation.
- Outcomes of Hepatitis C- and Hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
- The MELD score in advanced liver Disease: association with clinical portal hypertension and mortality.
- Mortality predictors in liver transplant recipients with recurrent hepatitis C Cirrhosis.
- Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
- MELD fails to measure quality of life in liver transplant candidates.
- Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
- Outcomes of acute rejection after interferon therapy in liver transplant recipients.
- Pretransplant variables associated with quality of life in liver transplant recipients.
- Nonalcoholic fatty liver Disease: pathogenesis, identification, progression, and management.
- Employment and quality of life in liver transplant recipients.
- Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C.
- Development and validation of a Disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0.
- Effect of nonviral factors on Hepatitis C recurrence after liver transplantation.
- Capsule Endoscopy Is Not as Accurate as Esophagogastroduodenoscopy in Screening Cirrhotic Patients for Varices.
- Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors.
- Development of a Disease-specific questionnaire to measure health-related quality of life in liver transplant recipients.
- De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis.
- Recurrence of hepatocellular carcinoma and Hepatitis B reinfection in Hepatitis B surface antigen-positive patients after liver transplantation.
- Health-related quality of life predicts mortality in patients with advanced chronic liver Disease.
- An explicit quality indicator set for measurement of quality of care in patients with Cirrhosis.
- Multinodular fatty liver after herpes-zoster vaccine: case report and review of the literature.
- Prospective validation of the short form liver Disease quality of life instrument.
- Posttransplantation Hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy.
- Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation.
- Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
- [Homage to the academic doctor Clemente Robles on the occasion of his 50th anniversary of entrance to the National Academy of Medicine].
- [Progress in the enzymatic determination for the diagnosis and evaluation of myocardial infarct].
- Current management of recurrent pyogenic cholangitis.
- Effect of single and repeated doses of metoclopramide on the mechanisms of gastroEsophageal reflux.
- Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid.
- Intraductal oncocytic papillary Neoplasm of the liver: case and review of a rare variant.
- Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, Cirrhosis and hepatocellular carcinoma.
- Nonalcoholic fatty liver Disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?
Schools
Universidad Autonoma Del Estado De Mexico Facultad De Medicina
Los Angeles County Usc Med Center
Lac Usc Med Center
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
Autonomous University of the State of Mexico
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1427070010 | |
| NPPES Provider LastName | DURAZO | |
| NPPES Provider FirstName | FRANCISCO | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 1975.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427070010 |
| Last Name Of The Provider | DURAZO |
| First Name Of The Provider | FRANCISCO |
| View All |
Similar Doctors
|
|
Dr. Daniel Brelian, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lin F. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Donovan, MD |
|
|
Dr. Pilsoo Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emeran A. Mayer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Rabindra R. Watson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amandeep K. Sahota, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karl K. Kwok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor H. Wu, MD |
|
|
Dr. Karl T. Esrason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James J. Farrell, MD |
|
|
Dr. Steven-Huy B. Han, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas A. Gardner, MD |
|
|
Dr. Neil Kaplowitz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. John M. Iskander, MD |
|
|
Dr. Jonathan D. Kaunitz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jim K. Tung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew H. Soll, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Barry A. Morquelan, MD |
|
|
Dr. Rebecca E. Slomovic, MD |
|
|
Dr. Ho S. Bae, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jihane N. Benhammou, MD |
|
|
Dr. Phillip S. Ge, MD |